CME Zone
IGIV Therapy: Current Clinical Practice and Future Directions
 
This supplement presents highlights from IGIV Therapy: Current Clinical Practice and Future Directions, a continuing education symposium held on December 3, 2007, during the American Society of Health-System Pharmacists 2007 Midyear Clinical Meeting. Dr. Jordan S. Orange addressed current issues on evidence-based prioritization of IGIV use, Dr. Carol Lee Koski discussed the emerging evidence supporting IGIV use in myasthenia gravis, and Dr. Jerry Siegel presented strategies for anticipating and managing adverse effects of IGIV therapy.

This activity is made possible by an unrestricted educational grant from Talecris Biotherapeutics.

Please contact Continuing Education Alliance at inquiries@cealliance.org for questions regarding this activity.


Release date: May 1, 2008
Expiration: May 1, 2009

		To access the program and to receive credit please click here